A once-a-day tablet for advanced breast cancer will be rolled out on the NHS. More than 1,000 women will be eligible for the drug elacestrant after a U-turn by the National Institute for Health ...

India’s Tata Institute of Fundamental Research (TIFR) has announced the development of a new pro-oxidant tablet, combining resveratrol and copper (R+Cu), that has the potential to prevent the ...

Daily low-dose aspirin can help prevent cancers from returning in about a third of colon cancer patients, a new study says.

Pain is one of the most common symptoms associated with cancer. It causes much concern to patients and their family members. Despite the existence of well known guidelines for cancer pain ...

A new once-a-day tablet that treats advanced breast cancer is to be rolled out on the NHS, with about 1,100 patients in England set to benefit. The final guidance on elacestrant by the National ...

Ranchi: Jharkhand health minister Irfan Ansari on Tuesday announced that 42,000 sahiyas (community health workers) will ...

Background and objectives: Patients with cancer, particularly those undergoing ... investigate the absorption profile of fentanyl buccal tablet (FBT) -- an effervescent formulation of fentanyl ...

A consultant analysing a mammogram of a woman’s breast (Rui Vieira/PA) A new once-a-day tablet that treats advanced breast cancer is to be rolled out on the NHS, with about 1,100 patients in ...